Nexiam (Esomeprazole Magnesium Trihydrate)

Esomeprazole, the active ingredient in Nexiam, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is employed in the management of acid‑related gastrointestinal disorders such as gastroesophageal reflux disease, erosive esophagitis, and conditions requiring acid suppression.

GNH USA supplies Nexiam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Esomeprazole acts on the gastric proton pump to lower acid production, making it useful for several acid‑related conditions.

- Gastroesophageal reflux disease (GERD): alleviates heartburn and regurgitation by reducing stomach acidity. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens by maintaining a less acidic gastric environment. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Adverse reactions may occur with esomeprazole use. Patients should be aware of both frequent and less common events.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea: occasional mild upset. - Abdominal pain: cramp‑like discomfort. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: abnormal liver function tests.

Before initiating therapy, consider the following safety measures.

- Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor for infection: prolonged acid suppression can predispose to gastrointestinal infections. - Evaluate bone health: long‑term use may affect calcium absorption. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Esomeprazole may affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: markedly decreased antiviral efficacy. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Digoxin: slight increase in serum levels, observe for toxicity. - Methotrexate (high dose): potential for increased toxicity, check renal function.